Alison Moore insider trades
Alison Moore has filed 18 Form 4s with the SEC that we hold, for Codexis, INC. (CDXS) (President and CEO, Director), Allogene Therapeutics, Inc. (ALLO) (Chief Technical Officer) and Artiva Biotherapeutics, Inc. (ARTV) (Director). Across all of them we count 0 purchases worth $0 and 4 sales worth $95.7K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($13.6K). The largest single trade was a sale of 8,698 shares of Allogene Therapeutics, Inc. worth $66.4K, dated 2022-03-15. Of 1 sale filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-03-17 and the latest 2026-10-14.
Codexis, INC. (CDXS)
Allogene Therapeutics, Inc. (ALLO)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-03-15 | S, sale reported on Form 4 | 8,698 | $66.4K | 2022-03-17 | SEC |
Artiva Biotherapeutics, Inc. (ARTV)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1754937) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
